Euronews is no longer accessible on Internet Explorer. This browser is not updated by Microsoft and does not support the last technical evolutions. We encourage you to use another browser, such as Edge, Safari, Google Chrome or Mozilla Firefox.

Gilead Sciences to hire Roche executive O'Day as new CEO - source

Gilead Sciences to hire Roche executive O'Day as new CEO - source
Roche Pharmaceuticals CEO Daniel O'Day attends a news conference in Basel, Switzerland February 1, 2017. REUTERS/Ruben Sprich -
Ruben Sprich(Reuters)
Euronews logo
Text size Aa Aa

(Reuters) - Drugmaker Gilead Sciences Inc <GILD.O> will name Roche Holding AG <ROG.S> executive Daniel O'Day as its new chief executive officer, according to a source familiar with the matter.

The announcement of O'Day's hiring could come as early as Monday, the source said.

It is not clear when O'Day, currently the CEO of Roche Pharmaceuticals, will start at Gilead.

Gilead said in July that current CEO John Milligan would step down as soon as the end of the year.

(Reporting by Liana Baker in New York; Writing by Ismail Shakil in Bengaluru; Editing by Peter Cooney)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on for a limited time.